University of Rochester · 5 months ago
Neurodiagnostic Tech Asst
The University of Rochester is committed to excellence and inclusivity, and they are seeking a Neurodiagnostic Tech Assistant. This role involves monitoring patients undergoing continuous EEG recording for safety, alerting staff during clinical events, and assisting in ensuring patient safety.
Health CareMedicalUniversities
Responsibilities
Monitors patients undergoing cEEG recording for safety
Alerts nursing and/or technologist staff when clinical seizures or other paroxysmal events occur
Assists in monitoring all EMU patients to ensure patient safety. Recognizes normal and abnormal EEG waveform patterns
Alerts physicians and supervising Neurophysiology technologist of clinical/subclinical seizures or behavioral arrest changes
Troubleshoots EEG reading in real time to minimize the risk of poor or incomplete data
Assists Neurodiagnostic Technologists as needed, including restocking supplies and electrode removal
Other duties as assigned
Qualification
Required
High School diploma or equivalent required
Or equivalent combination of education and experience
Will be trained in-house with 20 clinical observation hours and successful completion of didactic course (ASET LTM 100) and competency assessments including but not limited to recognition of clinical seizures and other clinical paroxysmal events, ictal testing procedures, measures to reduce risk of fall, and seizure first aid
Company
University of Rochester
The University of Rochester is a private research university located in Rochester, New York.
H1B Sponsorship
University of Rochester has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (234)
2024 (126)
2023 (130)
2022 (106)
2021 (100)
2020 (92)
Funding
Current Stage
Late StageTotal Funding
$20.43MKey Investors
National Science FoundationUnitedHealthcareSociety to Improve Diagnosis in Medicine
2023-09-25Grant· $18M
2023-07-26Grant· $0.07M
2022-09-20Grant· $0.05M
Recent News
2025-12-04
Company data provided by crunchbase